{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gardenin a", "anxiety", "convulsion", "depression", "sedative"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32181517", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "03", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1002/ddr.21659"], "Journal": {"ISSN": "1098-2299", "JournalIssue": {"Volume": "81", "Issue": "5", "PubDate": {"Year": "2020", "Month": "Aug"}}, "Title": "Drug development research", "ISOAbbreviation": "Drug Dev Res"}, "ArticleTitle": "Evaluation of the neuropharmacological effects of Gardenin A in mice.", "Pagination": {"StartPage": "600", "EndPage": "608", "MedlinePgn": "600-608"}, "Abstract": {"AbstractText": ["This work describes the neuropharmacological (sedative, anxiolytic, antidepressant, and anticonvulsant) actions of Gardenin A (GA) (0.1-25\u2009mg/kg p.o.), a flavonoid found in medicinal plants. The sedative effects of GA were assessed with the pentobarbital-induced sleep test. The anxiolytic actions of GA were evaluated with the elevated plus-maze, the light-dark box test, the exploratory cylinder assay, and the open field test. Motor coordination was evaluated with the rotarod test and the open field test. The antidepressant-like actions of GA were evaluated with the tail suspension test and forced swimming test. The mechanisms of the anxiolytic-like and antidepressant-like effects of GA were assessed using inhibitors of neurotransmission pathways. The anticonvulsant activity of GA was evaluated with the strychnine-induced seizure test. The sedative effects of GA were evident only at a dose of 25\u2009mg/kg, which increased the duration of sleep but did not alter sleep onset. GA showed anxiolytic-like actions with activity comparable to that of clonazepam in all experimental tests. The GABA<sub>A</sub> receptor antagonist bicuculline reversed the anxiolytic-like effects of GA. Furthermore, GA showed significant antidepressant-like actions in both models with activity comparable to that of fluoxetine. Yohimbine, an \u03b12-adrenoceptor blocker, inhibited the antidepressant-like actions of GA. In addition, GA (1-10 mg/kg) did not affect locomotor coordination in mice and delayed the onset of convulsions. These findings suggest that GA induces anxiolytic-like effects and has anticonvulsant actions by the possible involvement of the GABAergic system. The antidepressant-like actions of GA may be mediated by noradrenergic neurotransmission."], "CopyrightInformation": "\u00a9 2020 Wiley Periodicals, Inc."}, "AuthorList": [{"Identifier": ["0000-0003-2660-8156"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Guanajuato, Mexico."}], "LastName": "Alonso-Castro", "ForeName": "Angel J", "Initials": "AJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Juriquilla, Quer\u00e9taro, Mexico."}], "LastName": "Gasca-Mart\u00ednez", "ForeName": "Deisy", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Neurobiolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Juriquilla, Quer\u00e9taro, Mexico."}], "LastName": "Cortez-Mendoza", "ForeName": "Laura V", "Initials": "LV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Guanajuato, Mexico."}], "LastName": "Alba-Betancourt", "ForeName": "Clara", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Guanajuato, Mexico."}], "LastName": "Ruiz-Padilla", "ForeName": "Alan J", "Initials": "AJ"}, {"Identifier": ["0000-0003-0386-0121"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Farmacia, Divisi\u00f3n de Ciencias Naturales y Exactas, Universidad de Guanajuato, Guanajuato, Guanajuato, Mexico."}], "LastName": "Zapata-Morales", "ForeName": "Juan R", "Initials": "JR"}], "GrantList": [{"GrantID": "Evaluacion de los efectos antidepresivos y antibio", "Agency": "Secretar\u00eda de Salud del Estado de Guanajuato", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Drug Dev Res", "NlmUniqueID": "8204468", "ISSNLinking": "0272-4391"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anticonvulsants"}, {"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypnotics and Sedatives"}, {"RegistryNumber": "24J0W87Z43", "NameOfSubstance": "gardenin A"}, {"RegistryNumber": "H9Y79VD43J", "NameOfSubstance": "Strychnine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anticonvulsants"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Exploratory Behavior"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Flavones"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Hypnotics and Sedatives"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Rotarod Performance Test"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Seizures"}, {"QualifierName": [], "DescriptorName": "Strychnine"}, {"QualifierName": [], "DescriptorName": "Swimming"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abdallah, H. M., Zakaria, E. M., El-Halawany, A. M., Mohamed, G. A., Safo, M. K., & El-Bassossy, H. M. (2019). Psiadia punctulata major flavonoids alleviate exaggerated vasoconstriction produced by advanced glycation end products. PLoS One, 14(9), e0222101."}, {"Citation": "Bilkei-Gorzo, A., Racz, I., Michel, K., & Zimmer, A. (2002). Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. Journal of Neuroscience, 22(22), 10046-10052."}, {"Citation": "Cai, R. J., Wei, J., Jing, F. L., Zhao, G. Z., & Zhang, Y. (2017). Identification of metabolites of gardenin a in rat liver microsomes using ultra-high performance liquid chromatography coupled with linear ion-trap orbitrap mass spectrometry. Tropical Journal of Pharmaceutical Research, 16(2), 421-427."}, {"Citation": "Domschke, K., & Zwanzger, P. (2008). GABAergic and endocannabinoid dysfunction in anxiety - Future therapeutic targets? Current Pharmaceutical Design, 14(33), 3508-3517."}, {"Citation": "Fujimori, H. (1965). Potentiation of barbital hypnosis as an evaluation method for central nervous system depressants. Psychopharmacologia, 7(5), 374-378."}, {"Citation": "Griebel, G., Belzung, C., Perrault, G., & Sanger, D. J. (2000). Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology, 148(2), 164-170."}, {"Citation": "Gul\u00e7in, \u0130., Taslimi, P., Ayg\u00fcn, A., Sadeghian, N., Bastem, E., Kufrevioglu, O. I., \u2026 \u015een, F. (2018). Antidiabetic and antiparasitic potentials: Inhibition effects of some natural antioxidant compounds on \u03b1-glycosidase, \u03b1-amylase and human glutathione S-transferase enzymes. International Journal of Biological Macromolecules, 119, 741-746."}, {"Citation": "Hamm, R. J., Pike, B. R., O'Dell, D. M., Lyeth, B. G., & Jenkins, L. W. (1994). The rotarod test: An evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. Journal of Neurotrauma, 11(2), 187-196."}, {"Citation": "Hiller, K. O., & Zetler, G. (1996). Neuropharmacological studies on ethanol extracts of Valeriana officinalis L.: Behavioral and anticonvulsant properties. Phytotherapy Research, 10(2), 145-151."}, {"Citation": "Islas-Espinoza, A. M., Campos-Rodriguez, C., & Ram\u00edrez San Juan, E. (2018). Thalidomide protects against acute pentylenetetrazol and pilocarpine-induced seizures in mice. Journal of Toxicological Sciences, 43(11), 671-684."}, {"Citation": "Kandhare, A. D., Mukherjee, A. A., & Bodhankar, S. L. (2018). Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress. Asian Pacific Journal of Tropical Biomedicine, 8(7), 352-359."}, {"Citation": "Kirby, L. G., & Lucki, I. (1997). Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. Journal of Pharmacology and Experimental Therapeutics, 282(2), 967-976."}, {"Citation": "Li, S., Pan, M. H., Lai, C. S., Lo, C. Y., Dushenkov, S., & Ho, C. T. (2007). Isolation and syntheses of polymethoxyflavones and hydroxylated polymethoxyflavones as inhibitors of HL-60 cell lines. Bioorganic and Medicinal Chemistry, 15(10), 3381-3389."}, {"Citation": "Li, B., Wang, L., Sun, Z., Zhou, Y., Shao, D., Zhao, J., \u2026 Cui, R. (2014). The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice. PLoS One, 9(4), e93158."}, {"Citation": "Liao, J. F., Huang, S. Y., Jan, Y. M., Yu, L. L., & Chen, C. F. (1998). Central inhibitory effects of water extract of Acori graminei rhizoma in mice. Journal of Ethnopharmacology, 61(3), 185-193."}, {"Citation": "L\u00f3pez-Rubalcava, C., & Estrada-Camarena, E. (2016). Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. Journal of Ethnopharmacology, 186, 377-391."}, {"Citation": "Loscher, W., Honack, D., Fassbender, C. P., & Nolting, B. (1991). The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III Pentylenetetrazole seizure models. Epilepsy Research, 8, 171-189."}, {"Citation": "Millan, M. J. (2004). The role of monoamines in the actions of established and \u201cnovel\u201d antidepressant agents: A critical review. European Journal of Pharmacology, 500(1-3), 371-384."}, {"Citation": "Morimoto, K., Fahnestock, M., & Racine, R. J. (2004). Kindling and status epilepticus models of epilepsy: Rewiring the brain. Progress in Neurobiology, 73, 1-60."}, {"Citation": "Miyakawa, T., Yamada, M., Duttaroy, A., & Wess, J. (2001). Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. Journal of Neuroscience, 21(14), 5239-5250."}, {"Citation": "Nutt, D. J. (2006). The role of dopamine and norepinephrine in depression and antidepressant treatment. Journal of Clinical Psychiatry, 67(Suppl 6), 3-8."}, {"Citation": "O'Neill, M. F., Osborne, D. J., Woodhouse, S. M., & Conway, M. W. (2001). Selective imidazoline I2 ligands do not show antidepressant-like activity in the forced swim test in mice. Journal of Psychopharmacology, 15(1), 18-22."}, {"Citation": "Rang, H. P., Dale, M. M., & Ritter, J. M. (1998). Antiepileptic drugs and centrally acting muscle relaxants. In H. P. Rang, J. M. Ritter (Eds.), Pharmacology (3rd ed., pp. 596-608). London: Churchill Livingstone, Longman Group."}, {"Citation": "R\u00e9n\u00e9ric, J.-P., & Lucki, I. (1998). Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology, 136(2), 190-197."}, {"Citation": "Stone, E. A., & Quartermain, D. (1999). Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biological Psychiatry, 46(9), 1287-1300."}, {"Citation": "Taylor, C., Fricker, A. D., Devi, L. A., & Gomes, I. (2005). Mechanisms of action of antidepressants: From neurotransmitter systems to signaling pathways. Cell Signaling, 17(5), 549-557."}, {"Citation": "Toppo, E., Darvin, S. S., Esakkimuthu, S., Stalin, A., Balakrishna, K., Sivasankaran, K., \u2026 Al-Dhabi, N. A. (2017). Antihyperlipidemic and hepatoprotective effects of Gardenin a in cellular and high fat diet fed rodent models. Chemico-Biological Interactions, 269, 9-17."}, {"Citation": "Weninger, S. C., Dunn, A. J., Muglia, L. J., Dikkes, P., Miczek, K. A., Swiergiel, A. H., \u2026 Majzoub, J. A. (1999). Stress-induced behaviors require the CRH receptor, but not CRH. Proceedings of the National Academy of Sciences USA., 96(14), 8283-8288."}, {"Citation": "Zhang, J., Wang, F., Cai, W., Zhang, Q., Liu, Y., Li, Y., \u2026 Cao, G. (2015). Identification of metabolites of gardenin a in rats by combination of high-performance liquid chromatography with linear ion trap-Orbitrap mass spectrometer based on multiple data processing techniques. Biomedical Chromatography, 29(3), 379-387."}], "Title": "REFERENCES"}], "History": [{"Year": "2020", "Month": "1", "Day": "7"}, {"Year": "2020", "Month": "2", "Day": "29"}, {"Year": "2020", "Month": "3", "Day": "3"}, {"Year": "2020", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "3", "Day": "18", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32181517", "10.1002/ddr.21659"]}}]}